Fred Alger Management, LLC Prothena Corp Public LTD CO Transaction History

Fred Alger Management, LLC

  • $19.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$24.75 - $40.66 $18,018 - $29,600
-728 Reduced 2.16%
32,996 $817,000
Q4 2023

Feb 14, 2024
BUY
$32.31 - $52.32 $1.09 Million - $1.76 Million
33,724 New
33,724 $1.23 Million
Q2 2023

Aug 14, 2023
BUY
$48.26 - $78.59 $35,953 - $58,549
745 Added 3.49%
22,064 $1.51 Million
Q1 2023

May 15, 2023
BUY
$46.97 - $58.27 $1 Million - $1.24 Million
21,319 New
21,319 $1.03 Million

Others Institutions Holding PRTA

# of Institutions
185
Shares Held
42.8M
Call Options Held
162K
Put Options Held
102K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $668M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email